CAS RN: 1256255-94-3
6-Bromo-8-fluoro-3,4-dihydro-2H-1,4-benzoxazine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
96% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250224
250mg / 1g / 5g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1256255-94-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
1256255-94-3 / 6-bromo-8-fluoro-3,4-dihydro-2H-1,4-benzoxazine
Standard CAS: 1256255-94-3
Multi CAS: No
Basic Information
copy
CAS
1256255-94-3 copy
Multi CAS
No copy
Molecular Formula
C8H7BrFNO copy
Molecular Weight
232.050000 copy
Exact Mass
230.969500 copy
SMILES
C1COC2=C(N1)C=C(C=C2F)Br copy
InChI
InChI=1S/C8H7BrFNO/c9-5-3-6(10)8-7(4-5)11-1-2-12-8/h3-4,11H,1-2H2 copy
InChIKey
HPXAPSFLFJWDJH-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.25 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
48.08 copy
TPSA
21.26 copy
LogP / Solubility
WLOGP
2.39 copy
MLOGP
2.11 copy
XLogP3
2.4 copy
Consensus LogP
2.3 copy
Log S (ESOL)
-3.16 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.19 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.15 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.44 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy